Show
Sort by
-
Disease outcomes and patient’s perspectives after switching biologics from intravenous to subcutaneous administration : a real-world experience in a tertiary IBD-unit
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i2220-i2222 -
Pre-operative exposure to tofacitinib is as safe as biologics in patients with ulcerative colitis undergoing colectomy : a multicentre observational study
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i998-i999 -
Age-related patterns in biological therapy use and surgery among patients with IBD : insights from the Belgian PANTHER cohort
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i1125-i1127 -
Promising efficacy of biologicals and small molecules for microscopic colitis : results from a large real-life multicenter cohort
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i218-i220 -
The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i1739-i1740 -
- Conference Paper
- C3
- open access
3D bioprinting of gelatin derivatives : towards novel small intestinal in vitro models
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i293-i293